Loading
Latest filing published 13 Nov 2008 for NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, €5,273.
No signal scores available.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William A. Fletcher discloses dealings in Neurobiological Technologies Inc /CA/ to SEC (Form 4). Between 2 November 2007 and 27 October 2009, the trades on record add up to 5 filings.
On the market, this insider has only ever bought: 4 purchases, €96k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 option exercise.
A typical purchase (the median) is worth €5,369. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -5.9%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 29 October 2009: an option exercise of €6,580, in Neurobiological Technologies Inc /CA/. The last purchase on record was published on 13 November 2008, which is 6,554 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations